Covered recipient · General Payments record
ARELY CAVAZOS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$2,243.85
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $421.07 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $134.38 | 8 |
| Takeda Pharmaceuticals U.S.A., Inc. | $121.16 | 1 |
| Lilly USA, LLC | $50.55 | 2 |
| Ipsen Biopharmaceuticals, Inc | $34.87 | 1 |
| Janssen Biotech, Inc. | $26.73 | 1 |
| RedHill Biopharma Inc. | $23.44 | 1 |
| GENZYME CORPORATION | $15.92 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.92 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106895787 | CMS |
| ABBVIE INC. | $20.24 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106895789 | CMS |
| ABBVIE INC. | $15.64 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106895791 | CMS |
| ABBVIE INC. | $15.16 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106895793 | CMS |
| ABBVIE INC. | $7.60 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106895795 | CMS |
| ABBVIE INC. | $17.52 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106895797 | CMS |
| ABBVIE INC. | $10.89 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106895799 | CMS |
| ABBVIE INC. | $22.41 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106895801 | CMS |
| GENZYME CORPORATION | $15.92 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139783635 | CMS |
| Ipsen Biopharmaceuticals, Inc | $34.87 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091972958 | CMS |
| Janssen Biotech, Inc. | $26.73 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078741185 | CMS |
| Lilly USA, LLC | $26.62 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135567500 | CMS |
| Lilly USA, LLC | $23.93 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135551169 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.02 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151154401 | CMS |
| RedHill Biopharma Inc. | $23.44 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095477003 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $121.16 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137724010 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.